StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Vaccinex's price to sales ratio was 4.5× on Oct 19, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 2.2× to 161.1×, with a median of 13.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20264.5×−0.3
2025Dec 31, 20254.8×−1.8
2024Dec 31, 20246.6×+2.5
2023Dec 29, 20234.0×−41.1
2022Apr 29, 202245.2×+9.6
2021Dec 31, 202135.6×−68.3
2020Apr 30, 2020103.9×+26.2
2019Dec 31, 201977.7×–

More Vaccinex figures

See a number that looks wrong?